NCT00441610View on ClinicalTrials.gov

An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2009

Conditions
Advanced Solid Tumors
Interventions
DRUG

Gimatecan

Trial Locations (1)

Unknown

Novartis Investigative Site, Chiba

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00441610 - An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor | Biotech Hunter | Biotech Hunter